Sat Out APR's Rally? Here Is The Bet Holders Made

If APR was on your watchlist rather than in your portfolio, the outcome over this stretch may feel like a missed shot. For APR shareholders, the return from the start of the year was 22.6%, including dividends. That gain arrived as overseas expansion, B2B growth plans, and a large share repurchase program were already on record. If you rewind to January, how could you have judged whether APR’s aggressive global rollout would actually convert those ambitions into stronger earnings power?

A Narrative on Simply Wall St is one investor's written case for a company, with its growth, margin and multiple assumptions spelled out. Those assumptions imply an estimated Fair Value.

The easy part of this move is behind APR. Zero in on 194 high quality undervalued stocks for companies trading below our estimates.

The Two APR Stories Investors Were Weighing

The shares cost ₩230,000 at the start of the period, which left APR investors choosing between two very different stories about where the business might be heading next.

The bullish narrative put fair value at ₩262,950 and was based on APR executing its U.S. and Japan rollout, while a ₩300b buyback and cancellation plan supported earnings per share.

The bearish view anchored fair value at ₩76,000 and focused on the risk that heavier regulation on packaging and ingredients, plus demographic shifts in developed markets, could pressure demand and margins.

What APR’s Latest Results Actually Tested

The clearest new datapoint for APR was the Q2 2026 report. Revenue and net income were higher than in Q2 2025, which gave the optimistic expansion story fresh support. Net margin moved the other way though, slipping from 20.2% to 18.4%, so the stronger earnings power that bulls hoped for remained partly unproven.

The lesson is simple. When a growth plan is the main hook, do not just watch the top line. Track whether net margin and absolute profit move in the same direction as sales once new markets scale.

What APR’s Price Now Assumes After The Run

APR is now trading at ₩282,000, after a 22.6% gain from the start of the year. The selected Narrative’s Fair Value sits above the current price and ties that stance to how far APR can push its beauty devices and Medicube ecosystem outside Korea.

At this level, you are effectively judging whether the stock still under-reflects sustained overseas demand and the earnings impact of APR’s focus on higher margin beauty technology rather than legacy categories.

"Key Takeaways: Bullish analysts expect APR to keep compounding its global beauty and device franchises, with overseas markets, hero products, and blended online and offline channels supporting further gains in revenue scale and operating profit. The main requirement is that APR continues to build on its cosmetics and home beauty device growth while expanding offline and B2B distribution, without letting higher logistics and tariff costs erode its mid 20s operating margin profile."

That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for

Which Company Could Surprise You Next?

What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.

• Company 1 - 17% below our estimate - targets everyday supplement consumption by scaling production capacity and dedicated warehousing operations.
• Company 2 - 33% below our estimate - shortens subsea project delivery using bundled contracts and modular standardized deepwater equipment.
• Company 3 - 30% below our estimate - pushes into B2B video infrastructure using in-house AI tools to optimize products.

Those are three of them. See all 207 companies with the balance sheet to back it up →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com